- Bempedoic acid: Uses, Dosage, Side Effects, Warnings - Drugs. com
Bempedoic acid (brand name Nexletol) is an oral, non-statin, LDL cholesterol-lowering treatment that may be used in adults to: lower the risk of heart attack and heart procedures (for example stent placement or bypass surgery), in those unable to take recommended statin treatment (a cholesterol-lowering medicine), or are not taking a statin, who:
- Bempedoic acid (oral route) - Side effects dosage - Mayo Clinic
Description Bempedoic acid is used together with diet and other cholesterol-lowering medicines to reduce bad cholesterol (LDL) in patients with primary hyperlipidemia (high blood cholesterol), including heterozygous familial hypercholesterolemia (HeFH) Bempedoic acid is also used to lower the risk of heart attack and heart procedures (eg, stent placement or bypass surgery) in patients who are
- Is This New Medication Another Solution For High Cholesterol?
Bempedoic acid lowered cholesterol in people who are at high risk of heart disease by 21% Last month, the Journal of the American Medical Association (JAMA) published a study that explored the use of bempedoic acid ― a fairly new medication that was approved by the FDA in 2020 ― as a cholesterol-lowering drug
- Bempedoic Acid and Cardiovascular Outcomes in Statin . . .
In several studies, bempedoic acid reduced the level of LDL cholesterol by 17 to 28%, a finding that, in 2020, prompted its approval by the Food and Drug Administration and the European Medicines
- Nexletol (bempedoic acid) - Uses, Side Effects, and More
Find patient medical information for Nexletol (bempedoic acid) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
- Efficacy of Bempedoic Acid, Novel Treatment for Elevated LDL . . .
By Anthony Rice Bempedoic acid is a novel non-statin drug produced by Esperion Therapeutics to treat hypercholesterolemia, elevated levels of low-density lipoprotein (LDL) cholesterol in the blood 1 In the double-blind, placebo-controlled, phase 3 2022 CLEAR Outcomes trial conducted by Esperion, bempedoic acid treatment was associated with reductions in major adverse cardiovascular events
- Bempedoic Acid - StatPearls - NCBI Bookshelf
Bempedoic acid is a lipid-lowering agent pivotal in managing patients with elevated low-density lipoprotein cholesterol (LDL-C) levels The U S Food and Drug Administration (FDA) has sanctioned its use as an adjunct to maximally tolerated statin therapy for the reduction of LDL-C, specifically in individuals afflicted by atherosclerotic cardiovascular disease (ASCVD) and heterozygous familial
- Bempedoic Acid - Memorial Sloan Kettering Cancer Center
Bempedoic Acid This information from Lexicomp explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your healthcare provider
|